November 2025

Glaucoma Market to Hit $13.43 Billion by 2034 with 4.5% CAGR Growth The global glaucoma market is on a steady upward trajectory, projected to reach a staggering $13.43 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.5%. This growth is fueled by rising prevalence of glaucoma, advancements in treatment options, and […]

Top Eye Specialists in Northern Virginia Protect Your Vision Your vision is one of your most valuable senses, and ensuring its health should be a top priority. In Northern Virginia, a region known for its advanced medical facilities, top eye specialists are dedicated to providing exceptional care to protect and enhance your eyesight. Whether you

Best Strategies for Glaucoma and Cataract Patient Outcomes Glaucoma and cataracts are two of the most common eye conditions affecting millions of people worldwide. While they differ in their causes and progression, both can lead to significant vision impairment if not managed properly. Early detection, personalized treatment plans, and patient education are key to improving

Glaucoma Eye Drops Market Growth, Analysis, and Forecast to 2025 Introduction Glaucoma, a leading cause of irreversible blindness worldwide, affects millions of people. As prevalence rises, demand for effective treatments—especially glaucoma eye drops—is surging. The market is expected to grow significantly by 2025, fueled by pharmaceutical innovations, aging populations, and increased awareness about early diagnosis.

Innovative Minimally Invasive Glaucoma Treatments in Development Glaucoma, often called the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. For decades, treatment has relied on eye drops, laser therapy, or invasive surgeries. Now, advances in medical technology are introducing minimally invasive glaucoma surgeries (MIGS), offering safer procedures, faster recovery, and effective

Understanding Glaucoma: The Silent Thief of Sight Glaucoma is a group of eye diseases that damage the optic nerve, often linked to elevated intraocular pressure (IOP). Dubbed the “silent thief of sight,” it can cause irreversible vision loss without noticeable symptoms in its early stages. But here’s the pressing question: Can you reverse the damage

Perfuse Therapeutics Reports Positive Phase 1/2a Results for PER-001 Glaucoma Implant In a significant milestone for glaucoma treatment, Perfuse Therapeutics has announced encouraging results from its Phase 1/2a clinical trial for the PER-001 glaucoma implant. The novel device, designed to provide sustained intraocular pressure (IOP) reduction, demonstrated both safety and efficacy in early-stage testing, offering

Early Signs and Treatment Options for Glaucoma You Should Know Glaucoma is a serious eye condition that can lead to irreversible vision loss if not detected and treated early. Often referred to as the “silent thief of sight,” glaucoma progresses slowly and may not present noticeable symptoms until significant damage has occurred. Understanding the early

Remidio’s AI Tools for Glaucoma and AMD Gain CDSCO Approval The healthcare technology landscape is evolving rapidly, and artificial intelligence (AI) is at the forefront of this transformation. In a significant milestone, Remidio, a pioneering med-tech company, has secured approval from the Central Drugs Standard Control Organization (CDSCO) for its AI-powered diagnostic tools designed to